Dr. Edward King, MD
What this data tells you about Dr. King
Dr. Edward King is an urology physician in Ocala, FL, with 20 years in practice. Based on federal Medicare data, Dr. King performed 57,249 Medicare services across 4,946 unique beneficiaries.
Between the years covered by Open Payments, Dr. King received a total of $42,239 from 68 pharmaceutical and/or device companies across 565 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. King is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection | 40,600 | $0 | $0 |
| BCG treatment for bladder cancer | 3,800 | $2 | $5 |
| Injection, degarelix, 1 mg | 3,600 | $3 | $8 |
| Automated urinalysis | 2,279 | $2 | $5 |
| Office visit, established patient (20-29 min) | 1,388 | $64 | $227 |
| Blood draw (venipuncture) | 917 | $6 | $6 |
| Contrast dye for imaging (iodine-based) | 825 | $0 | $1 |
| Office visit, established patient (30-39 min) | 476 | $89 | $320 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 420 | $1 | $3 |
| Bladder ultrasound after voiding | 384 | $8 | $26 |
| Chronic care management, first 20 min/month | 365 | $49 | $159 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 300 | $3 | $8 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 244 | $135 | $336 |
| New patient office visit (45-59 min) | 232 | $121 | $422 |
| Drug injection, under skin or into muscle | 225 | $10 | $35 |
| Diagnostic exam of bladder and urethra using an endoscope | 217 | $64 | $608 |
| X-ray of abdomen, 1 view | 172 | $21 | $60 |
| Instillation of anti-cancer drug into bladder | 108 | $67 | $219 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 85 | $25 | $81 |
| Office visit, established patient (10-19 min) | 69 | $41 | $142 |
| Ultrasound scan of pelvic region through rectum | 63 | $25 | $74 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 59 | $16 | $57 |
| Mri scan of pelvis before and after contrast | 44 | $135 | $354 |
| Mri scan of pelvis without contrast | 42 | $94 | $240 |
| Biopsy of prostate gland | 30 | $102 | $612 |
| Simple insertion of temporary bladder tube | 28 | $44 | $156 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 28 | $228 | $735 |
| Injection procedure to cause erection | 27 | $67 | $221 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 23 | $123 | $809 |
| Hospital follow-up visit, moderate complexity | 22 | $64 | $179 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 21 | $368 | $1,061 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 19 | $170 | $628 |
| Initial hospital admission, moderate complexity | 19 | $106 | $333 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 18 | $138 | $992 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 16 | $26 | $162 |
| Insertion of device into abdomen with pressure and urine flow rate study | 13 | $150 | $489 |
| Dilation of urethra using an endoscope | 13 | $120 | $832 |
| Shock wave crushing of kidney stones | 12 | $486 | $1,460 |
| Electronic assessment of bladder emptying | 12 | $6 | $36 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 12 | $562 | $1,965 |
| Ct scan of abdomen and pelvis before and after contrast | 11 | $207 | $536 |
| New patient office visit (30-44 min) | 11 | $74 | $283 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for urology physician in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. King is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 7%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. King experienced with testosterone injection?
Does Dr. King receive payments from pharmaceutical companies?
How do Dr. King's costs compare to other urology physicians in Ocala?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology